Management of Increased Intracranial Pressure

Part of the following topical collections:
  1. Topical Collection on Critical Care Neurology

Opinion statement

After brain injury, neurologic intensive care focuses on the detection and treatment of secondary brain insults that may compound the initial injury. Increased intracranial pressure (ICP) contributes to secondary brain injury by causing brain ischemia, hypoxia, and metabolic dysfunction. Because ICP is easily measured at the bedside, it is the target of numerous pharmacologic and surgical interventions in efforts to improve brain physiology and limit secondary injury. However, ICP may not adequately reflect the metabolic health of the underlying brain tissue, particularly in cases of focal brain injury. As a result, ICP control alone may be insufficient to impact patients’ long-term recovery. Further studies are needed to better understand the combination of cerebral, hemodynamic, and metabolic markers that are best utilized to ensure optimal brain and systemic recovery and overall patient outcome after brain injury.


Intracranial pressure Treatment Traumatic brain injury Stroke Craniectomy Cerebrospinal fluid Brain edema Osmotic therapy Ventriculostomy 

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Becker DP, Miller JD, Ward JD, et al. The outcome from severe head injury with early diagnosis and intensive management. J Neurosurg. 1977;47:491–502.PubMedCrossRefGoogle Scholar
  2. 2.
    Nakagawa K, Smith WS. Evaluation and management of increased intracranial pressure. Continuum. 2011;17:1077–93.PubMedGoogle Scholar
  3. 3.
    Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001;56:1746–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Narayan RK, Greenberg RP, Miller JD, et al. Improved confidence of outcome prediction in severe head injury. A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressure. J Neurosurg. 1981;54:751–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Eisenberg HM, Frankowski RF, Contant CF, et al. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg. 1988;69:15–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Marmarou A, Anderson RL, Ward JD, et al. Impact of ICP instability and hypotension on outcome in patients with severe head trauma. J Neurosurg. 1991;75:S59–66.Google Scholar
  7. 7.
    Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma. 2007;24 Suppl 1:S55–8.PubMedGoogle Scholar
  8. 8.
    Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma. 2007;24 Suppl 1:S37–44.PubMedGoogle Scholar
  9. 9.•
    Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367:2471–81. This paper is the only large, randomized controlled study assessing the utility of intracranial pressure monitoring following traumatic brain injury to date.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Kahle KT, Duhaime AC. Intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2013;368:1750.PubMedGoogle Scholar
  11. 11.
    Ropper A. Brain in a box. N Engl J Med. 2012;367:2539–41.PubMedCrossRefGoogle Scholar
  12. 12.
    Schwab S, Aschoff A, Spranger M, et al. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology. 1996;47:393–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Poca MA, Benejam B, Sahuquillo J, et al. Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful? J Neurosurg. 2010;112:648–57.PubMedCrossRefGoogle Scholar
  14. 14.
    Gardner PA, Engh J, Atteberry D, Moossy JJ. Hemorrhage rates after external ventricular drain placement. J Neurosurg. 2009;110:1021–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51:170–81.PubMedCrossRefGoogle Scholar
  16. 16.
    Vik A, Nag T, Fredriksli OA, et al. Relationship of “dose” of intracranial hypertension to outcome in severe traumatic brain injury. J Neurosurg. 2008;109:678–84.PubMedCrossRefGoogle Scholar
  17. 17.
    Sheth KN, Stein DM, Aarabi B, et al. Intracranial pressure dose and outcome in traumatic brain injury. Neurocrit Care. 2013;18:26–32.PubMedCrossRefGoogle Scholar
  18. 18.
    Kahraman S, Dutton RP, Hu P, et al. Automated measurement of “pressure times time dose” of intracranial hypertension best predicts outcome after severe traumatic brain injury. J Trauma. 2010;69:110–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Bekar A, Gören S, Korfali E, et al. Complications of brain tissue pressure monitoring with a fiberoptic device. Neurosurg Rev. 1998;21:254–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosner MJ, Coley IB. Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg. 1986;65:636–41.PubMedCrossRefGoogle Scholar
  21. 21.
    Ng I, Lim J, Wong HB. Effects of head posture on cerebral hemodynamics: its influences on intracranial pressure, cerebral perfusion pressure, and cerebral oxygenation. Neurosurgery. 2004;54:593–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Raichle ME, Plum F. Hyperventilation and cerebral blood flow. Stroke. 1972;3:566–75.PubMedCrossRefGoogle Scholar
  23. 23.
    Stocchetti N, Maas AIR, Chieregato A, van der Plas AA. Hyperventilation in head injury: a review. Chest. 2005;127:1812–27.PubMedCrossRefGoogle Scholar
  24. 24.
    Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care. 2004;1:219–33.PubMedCrossRefGoogle Scholar
  25. 25.
    Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2 %) in 6 % hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med. 2006;34:2912–7.PubMedGoogle Scholar
  26. 26.
    White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006;102:1836–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med. 2000;28:3301–13.PubMedCrossRefGoogle Scholar
  28. 28.
    Wells DL, Swanson JM, Wood GC, et al. The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma. Crit Care. 2012;16:R193.PubMedCrossRefGoogle Scholar
  29. 29.
    Murad A, Ghostine S, Colohan ART. Controlled lumbar drainage in medically refractory increased intracranial pressure. Acta Neurochir. 2008;102(Suppl):89–91.Google Scholar
  30. 30.
    Bauer DF, McGwin G, Melton SM, et al. Risk factors for conversion to permanent ventricular shunt in patients receiving therapeutic ventriculostomy for traumatic brain injury. Neurosurgery. 2011;68:85–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Rea GL, Rockswold GL. Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery. 1983;12:401–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Marshall GT, James RF, Landman MP, et al. Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients. J Trauma. 2010;69:275–83.PubMedCrossRefGoogle Scholar
  33. 33.
    Marshall LF, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury. J Neurosurg. 1979;50:26–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Roberts I, Sydenham E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev. 2012;12, CD000033.PubMedGoogle Scholar
  35. 35.
    Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol. 2007;6:215–22.PubMedCrossRefGoogle Scholar
  36. 36.
    Jüttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–25.PubMedCrossRefGoogle Scholar
  37. 37.
    Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multi-center, open, randomized trial. Lancet Neurol. 2009;8:326–33.PubMedCrossRefGoogle Scholar
  38. 38.
    Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multi-center, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38:2506–17.PubMedCrossRefGoogle Scholar
  39. 39.
    Geurts M, van der Worp HB, Kappelle LJ, et al. Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial. Stroke. 2013;44:2506–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Zhao J, Su YY, Zhang Y, et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old. Neurocrit Care. 2012;17:161–71.PubMedCrossRefGoogle Scholar
  41. 41.
    Puetz V, Campos CR, Eliasziw M, et al. Assessing the benefits of hemicraniectomy: what is a favourable outcome? Lancet Neurol. 2007;6:580.PubMedCrossRefGoogle Scholar
  42. 42.
    Rahme R, Zuccarello M, Kleindorfer D, et al. Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction: is life worth living? J Neurosurg. 2012;117:749–54.PubMedCrossRefGoogle Scholar
  43. 43.
    Danish SF, Barone D, Lega BC, Stein SC. Quality of life after hemicraniectomy for traumatic brain injury in adults: a review of the literature. Neurosurg Focus. 2009;26:E2.PubMedCrossRefGoogle Scholar
  44. 44.••
    Kolias AG, Kirkpatrick PJ, Hutchinson PJ. Decompressive craniectomy: past, present and future. Nat Rev Neurol. 2013;9:405–15. This review article provides a thorough and comprehensive review of the use of surgical craniectomy for the management of a variety of severe brain injuries and the ethical implications of this procedure.PubMedCrossRefGoogle Scholar
  45. 45.
    Whitfield PC, Patel H, Hutchinson PJ, et al. Bifrontal decompressive craniectomy in the management of posttraumatic intracranial hypertension. Br J Neurosurg. 2001;15:500–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Aarabi B, Hesdorffer DC, Ahn ES, et al. Outcome following decompressive craniectomy for malignant swelling due to severe head injury. J Neurosurg. 2006;104:469–79.PubMedCrossRefGoogle Scholar
  47. 47.
    Cooper DJ, Rosenfeld JV, Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364:1493–502.PubMedCrossRefGoogle Scholar
  48. 48.
    Attia J, Cook DJ. Prognosis in anoxic and traumatic coma. Crit Care Clin. 1998;14:497–511.PubMedCrossRefGoogle Scholar
  49. 49.
    Sahuquillo J, Martínez-Ricarte F, Poca MA. Decompressive craniectomy in traumatic brain injury after the DECRA trial. Where do we stand? Curr Opin Crit Care. 2013;19:101–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Austinat M, Braeuninger S, Pesquero JB, et al. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke. 2009;40:285–93.PubMedCrossRefGoogle Scholar
  51. 51.
    Raslan F, Schwarz T, Meuth SG, et al. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood–brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010;30:1477–86.PubMedCrossRefGoogle Scholar
  52. 52.
    Albert-Weissenberger C, Stetter C, Meuth SG, et al. Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J Cereb Blood Flow Metab. 2012;32:1747–56.PubMedCrossRefGoogle Scholar
  53. 53.
    Shakur H, Andrews P, Asser T, et al. The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury. Trials. 2009;10:109.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Kunz M, Nussberger J, Holtmannspoetter M, et al. Bradykinin in blood and CSF after acute cerebral lesions: correlations with cerebral edema and intracranial pressure. J Neurotrauma. 2013; [Ahead of print].Google Scholar
  55. 55.
    Deutsch ER, Espinoza TR, Atif F, et al. Progesterone’s role in neuroprotection: a review of the evidence. Brain Res. 2013;1530:82–105.PubMedCrossRefGoogle Scholar
  56. 56.
    Shahrokhi N, Khaksari M, Soltani Z, et al. Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury. Eur J Neurol. 2010;88:414–21.Google Scholar
  57. 57.
    Yan F, Hu Q, Chen J, Wu C, Gu C, Chen G. Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett. 2013;543:163–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Wright DW, Kellermann AL, Hertzberg VS, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007;49:391–402.PubMedCrossRefGoogle Scholar
  59. 59.
    Simard JM, Chen M, Tarasov KV, et al. Newly expressed SUR1-regulated NC (Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433–40.PubMedCentralPubMedCrossRefGoogle Scholar
  60. 60.
    Simard JM, Woo SK, Schwartzbauer GT, Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab. 2012;32:1699–717.PubMedCrossRefGoogle Scholar
  61. 61.
    Sheth KN. Novel approaches to the primary prevention of edema after ischemia. Stroke. 2013;44:S136.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of NeurologyHospital of the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Division of Neurocritical Care and Emergency Neurology, Department of NeurologyYale UniversityNew HavenUSA

Personalised recommendations